Neoplasm
Not recruitingStudy of Pembrolizumab for Patients with Advanced Solid Tumors
Study of Pembrolizumab for Patients with Advanced Solid Tumors
- Disease:Neoplasm
- Substances:–
Denmark- Participants:18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
Study of Pembrolizumab for Patients with Advanced Solid Tumors
DenmarkStudy of LY3473329 for Adults with High Lipoprotein(a) Levels at Risk for Heart Problems
GermanyStudy on the Long-term Use of Pramipexole for Patients with Anhedonic Depression
SwedenStudy on Acetazolamide with Radiochemotherapy or Radioimmunotherapy for Patients with Small Cell Lung Cancer
FranceStudy Comparing Olaparib and Pembrolizumab with Chemotherapy and Pembrolizumab for Patients with Advanced Triple-Negative Breast Cancer
FranceStudy of DKN-01 with Drug Combination for Patients with Advanced Colorectal Cancer
GermanyStudy on Brexucabtagene Autoleucel for Adults with Relapsed or Refractory Burkitt Lymphoma
AustriaStudy on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Hairy Cell Leukemia
AustriaStudy on MK-7684A and Docetaxel for Treating Metastatic Non-Small Cell Lung Cancer in Patients After Platinum Chemotherapy and Immunotherapy
AustriaStudy on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Richter Transformation (RT)
AustriaStudy on the Effects of Horse Chestnut Seed Extract on Swelling and Pain in Patients After Meniscus Surgery
GermanyStudy on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Waldenstrom Macroglobulinemia Using a Drug Combination
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.